EASD: Daily Orforglipron Pill Shows Comparable Cardiovascular Safety to Insulin Glargine

WEDNESDAY, Oct. 14, 2026-- The daily orforglipron pill has comparable cardiovascular safety to insulin glargine daily injections while providing additional benefits for adults with type 2 diabetes at increased cardiovascular risk, according to a...